Ignite Creation Date:
2024-05-06 @ 7:24 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02523014
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2015-08-11
Brief Title:
Vismodegib FAK Inhibitor GSK2256098 Capivasertib and Abemaciclib in Treating Patients with Progressive Meningiomas
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Alliance for Clinical Trials in Oncology
Organization Data
Organization:
Alliance for Clinical Trials in Oncology
Class:
OTHER
Study ID:
A071401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Brain Science Foundation | UNKNOWN |
| National Cancer Institute NCI | NIH |
| GlaxoSmithKline | INDUSTRY |
| Genentech Inc | INDUSTRY |